WASHINGTON, DC
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION, founded in 1988, is a major nonprofit in the Medical Research sector that reported $162.3M in total revenue in fiscal year 2023. Revenue decreased 6% compared to the prior year.
THE ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION (EGPAF) IS A PROVEN LEADER IN THE FIGHT AGAINST PEDIATRIC HIV/AIDS AND HAS REACHED OVER 33 MILLION PREGNANT WOMEN WITH SERVICES TO PREVENT TRANSMISSION OF HIV TO THEIR BABIES. TO DATE, EGPAF HAS SUPPORTED OVER 15,000 SITES TO OFFER INTEGRATED HIV COUNSELING, PREVENTION, DIAGNOSIS, AND TREATMENT SERVICES ALONGSIDE HIGH-QUALITY FAMILY HEALTH CARE. CURRENTLY, EGPAF'S GLOBAL FOOTPRINT SPANS 19 COUNTRIES, 17 OF WHICH ARE IN SUB-SAHARAN AFRICA. EGPAF IS COMMITTED TO A COMPREHENSIVE RESPONSE TO THE GLOBAL FIGHT TO END HIV AND AIDS THROUGH RESEARCH, GLOBAL ADVOCACY, STRENGTHENING OF LOCAL HEALTH CARE SYSTEMS, AND GROWING THE CAPACITY OF GOVERNMENTS AND COMMUNITIES IN THE WORLD'S MOST AFFECTED REGIONS TO RESPOND TO URGENT NEEDS.
EGPAF WORKS WITH PUBLIC AND PRIVATE PARTNERS TO SUPPORT THE PROVISION AND EXPANSION OF HIV PREVENTION, CARE, AND TREATMENT TO ALL CHILDREN, WOMEN, AND FAMILIES AFFECTED BY HIV IN ORDER TO ACHIEVE AND...
EGPAF WORKS WITH PUBLIC AND PRIVATE PARTNERS TO SUPPORT THE PROVISION AND EXPANSION OF HIV PREVENTION, CARE, AND TREATMENT TO ALL CHILDREN, WOMEN, AND FAMILIES AFFECTED BY HIV IN ORDER TO ACHIEVE AND SUSTAIN AN AIDS-FREE GENERATION. STRENGTHENING HEALTH SYSTEMS, AND INTEGRATING HIV SERVICES WITH PRIMARY HEALTH CARE SERVICES, PARTICULARLY MATERNAL AND CHILD HEALTH SERVICES, IS CRITICAL TO ACHIEVING THIS GOAL.
EGPAF PLAYS A CRITICAL ROLE IN BOTH DEFINING THE PEDIATRIC AIDS RESEARCH AGENDA AND SUPPORTING AND CONDUCTING RESEARCH TO IMPROVE THE LIVES OF WOMEN, YOUTH, AND FAMILIES AFFECTED BY HIV. EGPAF LEADS...
EGPAF PLAYS A CRITICAL ROLE IN BOTH DEFINING THE PEDIATRIC AIDS RESEARCH AGENDA AND SUPPORTING AND CONDUCTING RESEARCH TO IMPROVE THE LIVES OF WOMEN, YOUTH, AND FAMILIES AFFECTED BY HIV. EGPAF LEADS STUDIES IN CLINICAL, LABORATORY, AND IMPLEMENTATIONS SCIENCE RESEARCH. ITS FOCUS IS OPTIMIZING HEALTH SERVICE DELIVERY; BUILDING AN EVIDENCE BASE FOR NEW AND INNOVATIVE INTERVENTIONS; AND EFFECTIVELY SCALING UP PROMISING HIV AND MATERNAL, NEWBORN, AND CHILD HEALTH INTERVENTIONS.
EGPAF'S PUBLIC POLICY AND ADVOCACY TEAM BUILDS ON ELIZABETH GLASER'S LEGACY OF FIGHTING FOR THE BEST POLICIES FOR WOMEN, YOUTH, AND FAMILIES LIVING WITH AND AFFECTED BY HIV. WITH STAFF ON THREE...
EGPAF'S PUBLIC POLICY AND ADVOCACY TEAM BUILDS ON ELIZABETH GLASER'S LEGACY OF FIGHTING FOR THE BEST POLICIES FOR WOMEN, YOUTH, AND FAMILIES LIVING WITH AND AFFECTED BY HIV. WITH STAFF ON THREE CONTINENTS, EGPAF IS WELL POSITIONED TO CHAMPION CHILDREN'S RIGHTS IN SEVERAL REALMS-INCLUDING THOSE OF NATIONAL GOVERNMENTS, AFRICAN REGIONAL BODIES, AND MULTILATERAL ORGANIZATIONS-TO PRODUCE VICTORIES FOR CHILDREN AND ADOLESCENTS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $162,295,489 | $172,481,008 | -0.1% |
| Expenses | $162,458,737 | $172,087,793 | -0.1% |
| Net Income | $-163,248 | $393,215 | -1.4% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Charles J Lyons II | PRESIDENT AND CEO | 40.0 |
Officer
Director
|
$537,395 | $39,880 | $577,275 |
| PATRICIA DEVINE KARLIN | EVP, EX AFFAIRS & BUS DEV | 40.0 |
Officer
|
$354,013 | $44,008 | $398,021 |
| Adriaantje Giphart | EVP, MED & SCI AFFAIRS | 40.0 |
Officer
|
$333,076 | $46,685 | $379,761 |
| Craig Molyneaux | CHIEF OPERATING OFFICER | 40.0 |
Officer
|
$313,583 | $44,008 | $357,591 |
| DOUGLAS HORNER | VP, AWARDS, COMPLIANCE & OPERA | 40.0 |
Key Emp
|
$285,216 | $46,450 | $331,666 |
| Appolinaire Tiam | VP, TECHNICAL STRATEGY & INNOV | 40.0 |
Key Emp
|
$259,754 | $42,518 | $302,272 |
| Allan Ahimbisibwe | Dep Country Director, Programs | 40.0 |
Highest
|
$262,790 | $19,306 | $282,096 |
| Shabbir Ismail Argaw | SR. DIRECTOR, STRATEGIC INFORM | 40.0 |
Highest
|
$234,562 | $41,426 | $275,988 |
| TAMARA L WARD-DAHL | VP, HUMAN RESOURCES & ADMIN | 40.0 |
Key Emp
|
$232,888 | $39,602 | $272,490 |
| Catherine Connor | VP, Program Imp & Country Mgmt | 40.0 |
Key Emp
|
$224,916 | $25,068 | $249,984 |
| Pauline Devinger | SR. DIRECTOR, INTERNAL AUDIT | 40.0 |
Highest
|
$206,832 | $39,147 | $245,979 |
| Yolanda Brignoni | VP, Ext Affairs (AS OF 01/23) | 40.0 |
Key Emp
|
$218,240 | $24,782 | $243,022 |
| Roland Van de Ven | TECHNICAL DIRECTOR, TANZANIA | 40.0 |
Highest
|
$217,798 | $17,351 | $235,149 |
| Paul Fisher | CHIEF DEVELOPMENT OFFICER | 40.0 |
Key Emp
|
$208,649 | $22,796 | $231,445 |
| Veena Sampathkumar | VP Prog Impl & Country Mgmt | 40.0 |
Key Emp
|
$209,188 | $19,704 | $228,892 |
| Jill Mathis | Sr Advisor Rev Mob & P'ship | 40.0 |
Key Emp
|
$199,621 | $22,949 | $222,570 |
| MAHOUDO BONOU | TECHNICAL DIRECTOR, MOZAMBIQUE | 40.0 |
Highest
|
$204,277 | $6,813 | $211,090 |
| Caspian Chouraya | COUNTRY DIRECTOR, SWAZILAND | 40.0 |
Key Emp
|
$178,954 | $24,185 | $203,139 |
| Sherian Abramaitys-Yi | Chief HR Officer (AS OF 06/23) | 40.0 |
Key Emp
|
$149,642 | $6,085 | $155,727 |
| Jack Leslie | CHAIRMAN OF THE BOARD | 0.5 |
Director
|
$0 | $0 | $0 |
| Kathleen Cravero-Kristoffersson | CO-VICE CHAIR | 0.5 |
Director
|
$0 | $0 | $0 |
| Janice Bashford | BOARD MEMBER (AS OF 3/23) | 0.5 |
Director
|
$0 | $0 | $0 |
| NATALIE BURTSON | BOARD MEMBER | 0.5 |
Director
|
$0 | $0 | $0 |
| Carlos Carrazana | BOARD MEMBER | 0.5 |
Director
|
$0 | $0 | $0 |
| Senator Christopher Dodd | BOARD MEMBER | 0.5 |
Director
|
$0 | $0 | $0 |
| Shannon Hader | BOARD MEMBER (AS OF 3/23) | 0.5 |
Director
|
$0 | $0 | $0 |
| Josephine Nabukenya | BOARD MEMBER | 0.5 |
Director
|
$0 | $0 | $0 |
| Dr Deborah Persaud | BOARD MEMBER (AS OF 3/23) | 0.5 |
Director
|
$0 | $0 | $0 |
| Blessing Rugara | BOARD MEMBER | 0.5 |
Director
|
$0 | $0 | $0 |
| Mary Karen Wills | BOARD MEMBER | 0.5 |
Director
|
$0 | $0 | $0 |
| Susie Zeegen | BOARD MEMBER | 0.5 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $162,295,489 | $162,458,737 | $41,655,184 | $-163,248 |
| 2022 | $172,481,008 | $172,087,793 | $42,359,587 | $393,215 |
| 2021 | $187,687,168 | $185,043,941 | $36,264,265 | $2,643,227 |
| 2020 | $165,216,570 | $168,062,128 | $33,395,440 | $-2,845,558 |
| 2019 | $202,227,730 | $201,028,105 | $37,379,584 | $1,199,625 |
| 2018 | $199,909,040 | $199,862,241 | $37,610,250 | $46,799 |
Compare ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION with other nonprofits in District of Columbia and across the country.